The Fast-track Centre for Hip and Knee Replacement Database (FCD)

August 6, 2024 updated by: Christoffer Joergensen, Rigshospitalet, Denmark

The Fast-track Centre for Hip and Knee Replacement Prospective Database on Preoperative Patientcharacteristics and Postoperative Complications

This is a prospective study-registry on preoperative patient characteristics and postoperative complications in patients having fast-track hip and knee replacement surgery in 8 Danish dedicated arthroplasty departments from all five health regions in Denmark. The registry consists of detailed patient and physician reported preoperative characteristics and including prescribed medication and lab results. Follow-up is based on electronical medical records by dedicated nurses with physician backup and includes Clavien-Dindo and Comprehensive Complication Index scoring. All patients having day-surgery also completes a patient reported questionaire on health-care utilization and return to work by day 30. Finally, a machine-learning algorithm for identification of "high-risk" patients based on he preoperative data is included.

Study Overview

Detailed Description

The study registry is intended for further detailed research on postoperative morbidity, feasibility and safety of day surgery and functional outcomes after fast-track hip and knee replacement in 8 dedicated Danish arthroplasty wards across all five health care regions in Denmark. The work is a continuation of the Lundbeck Foundation Centre Database on Hip and Knee Replacement also registered in ClinicalTrials but ceased enrolling in august 2017.

The aim of the registry is to provide standardized and comprehensive information on preoperative patient characteristics and postoperative complications, patient reported outcome measures and health-care utilization in fast-track hip and knee replacement within a socialized health-care system. Each department have dedicated research personel assuring registration and follow-up supervised by a datamanager, and with database-support from the Danish health Region of Southern Denmark.

All departments have similar established fast-track protocols as standard of care, but with focus on dividing patients into day-surgery, main fast-track group and high-risk cohorts.

Preoperative data includes information on prescribed medication, Clinical Frailty Score using CFS v.1, evaluation of Pain Catastrophizing Scale as well as laboratory testing of hemoglobin, kidney function, Hb1Ac in diabetics and C-reactive protein level. On the basis of the collected preoperative data a machine-learning algorithm for identifying the "high-risk" patients is being refined and with planned induction in the database.

Study Type

Observational

Enrollment (Estimated)

80000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Capital Region
      • Copenhagen, Capital Region, Denmark
        • Recruiting
        • Bispebjerg University Hospital
        • Contact:
        • Principal Investigator:
          • Søren Overgaard
      • Gentofte, Capital Region, Denmark
        • Recruiting
        • Gentofte University Hospital
        • Contact:
        • Principal Investigator:
          • Mikkel Rathsach, MD
      • Hvidovre, Capital Region, Denmark, 2650
        • Recruiting
        • Hvidovre Hospital
        • Contact:
        • Principal Investigator:
          • Kirill Gromov, M.D
    • Region Of Middle Judland
      • Herning, Region Of Middle Judland, Denmark
        • Active, not recruiting
        • Gødstrup Hospital
    • Region Of Northern Judland
      • Farsø, Region Of Northern Judland, Denmark, 9640
        • Recruiting
        • Aalborg University Hospital, Farsø
        • Contact:
        • Principal Investigator:
          • Thomas Jakobsen, M.D
    • Region Of Sourthern Denmark
      • Vejle, Region Of Sourthern Denmark, Denmark, 7100
        • Recruiting
        • Lillebaelt Hospital, Vejle
        • Contact:
        • Principal Investigator:
          • Claus Varnum, MD
    • Region Of Southern Denmark
      • Svendborg, Region Of Southern Denmark, Denmark
        • Recruiting
        • University Hospital Svendborg
        • Contact:
        • Principal Investigator:
          • Martin Lindberg-Larsen, M.D.
    • Region Seeland
      • Næstved, Region Seeland, Denmark
        • Recruiting
        • Næstved Hospital
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

The participating dedicated arthroplasty departments are placed in either large university or regional hospitals. The departments cover all five healthcare regions in Denmark and are estimated to contribute with about 40% of the annual hip and knee replacements in Denmark. Thus, the population is representative of the general Danish arthroplasty population.

Description

Inclusion Criteria:

  • age >18 years
  • non-malignant surgery
  • danish social security number
  • elective procedure

Exclusion Criteria:

  • unwilling to provide informed consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Day-surgery group
Patients having hip or knee replacement as day-surgery with successful discharge to own home on day of surgery
Standard surgical procedure but with planned discharge on day of surgery
High-risk patients
Patients evaluated to be at increased risk of postoperative complications. These patients will receive relevant additional attention based on type of comorbidity. I.e. preoperative evaluation of iron status and i.v. iron treatment in case of preoperative anaemia, increased focus on avoidance of NSAIDs and adequate fluid therapy in patients with renal disease etc.
Standard fast-track procedure but with additional perioperative measures dependent on risk-profile.
Main group
Patients who are not scheduled for day-surgery and without comorbidities qualifying as "high-risk". These patients go through a standard fast-track procedure with discharge to own home when fulfilling functional discharge criteria.
Standard fast-track procedure according to usual standard of care and discharge when fulfilling functional discharge criteria

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fraction of unselected patients able to undergo day-surgery procedures
Time Frame: 7 days postoperatively
The fraction patients eligible for day-surgery who are discharged on day of surgery.
7 days postoperatively
postoperative morbidity
Time Frame: 90 days postoperatively
postoperative morbidity resulting in prolonged (>2 days) hospitalisation, readmissions or mortality 90 days after surgery.
90 days postoperatively
postoperative morbidity Clavien-Dindo
Time Frame: 90 days postoperatively
Postoperative morbidity resulting in prolonged (>2 days) hospitalisation, readmissions or mortality 90 days after surgery according to the Clavien-Dindo index.
90 days postoperatively
postoperative morbidity CCI
Time Frame: 90 days postoperatively
Postoperative morbidity resulting in prolonged (>2 days) hospitalisation, readmissions or mortality 90 days after surgery according to the Comprehensive Complication Index
90 days postoperatively

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Healthcare utilisation in day-surgery
Time Frame: 30 days postoperatively
Registration of emergency room visits, visits to general practitioners and use of medical emergency services within 30 days after having hip or knee replacement as day-surgery procedure.
30 days postoperatively

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
return to work in day-surgery
Time Frame: 30 days postoperatively
changes in work status and time to return to work in day-surgery procedures
30 days postoperatively
patient satisfaction and patient reported outcome measures1
Time Frame: Baseline, 90 and 365 days postoperatively
collection of data on patient satisfaction and function after surgery using the EQ-5D-5L (score from 0-100 with increasing score indicating better health)
Baseline, 90 and 365 days postoperatively
patient satisfaction and patient reported outcome measures, THA only.
Time Frame: Baseline, 90 and 365 days postoperatively
collection of data on patient satisfaction and function after surgery using the Oxford Hip Score (range from 0-48 with increasing score indicating better function).
Baseline, 90 and 365 days postoperatively
patient satisfaction and patient reported outcome measures, TKA only.
Time Frame: Baseline, 90 and 365 days postoperatively
collection of data on patient satisfaction and function after surgery using the Oxford Knee score (range from 0-48 with increasing score indicating better function).
Baseline, 90 and 365 days postoperatively

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2022

Primary Completion (Estimated)

December 31, 2025

Study Completion (Estimated)

December 31, 2027

Study Registration Dates

First Submitted

October 19, 2022

First Submitted That Met QC Criteria

November 10, 2022

First Posted (Actual)

November 14, 2022

Study Record Updates

Last Update Posted (Actual)

August 9, 2024

Last Update Submitted That Met QC Criteria

August 6, 2024

Last Verified

August 1, 2024

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Patient Satisfaction

Clinical Trials on Day-surgery

Subscribe